North America

The prices of Vancomycin Hydrochloride fluctuated in the North American market throughout the third quarter of 2022, backed by wavering downstream demand from the pharmaceutical sector. The market value of Vancomycin Hydrochloride decreased in August due to reduced demand from the downstream pharmaceutical industry. Also, with enough existing inventories among domestic merchants and traders, the Vancomycin Hydrochloride API market was feeble. Overall, throughout Q3 2022, the prices increased with rising inflation in the US market, keeping the market sentiments robust. The input cost and firm operational rates propelled the market to witness decreasing trajectory. High input costs and increased freight charges positively supported the Vancomycin Hydrochloride prices in the domestic region. With the termination of Q3, the prices settled at USD 705530/MT CFR Los Angeles with an average quarterly inclination of 1.20%.


The third quarter of 2022 saw conflicting emotions in the Vancomycin Hydrochloride market. Production in Chinese provinces ceased at the start of Q3 2022 due to adverse weather conditions and the ramifications of the strict zero-covid rule. Due to sluggish pharmaceutical industry demand, prices abruptly dropped. Due to consistent demand and supply market sentiments through the conclusion of the second month of Q3, the price trend remained downward. The destocking of the current supply also impacted the Pricing of Sulfamethoxazole. Price increases in Asia-Pacific started in the third month of Q3 2022 due to supply chain disruption and unbalanced shipments. In addition, many changes in supply and demand throughout the quarter impacted domestic market prices for vancomycin hydrochloride. The value reached USD 630460 /MT at the end of Q3, with an average quarterly declination of 0.99%


Due to irregular downstream demand, Vancomycin Hydrochloride market prices fluctuated in the European countries during the third quarter. The market value of Vancomycin Hydrochloride first increased in July, then decreased in August, and then expanded once more in September. Altogether the market trend declined in the third quarter of 2022. The significant fall in the prices of Vancomycin Hydrochloride API was backed by decreasing demand from the pharmaceutical industry. Also, enough inventories among the domestic merchants and suppliers forced them to lower their quotations to maintain the margin. Also, rising inflation propelled decreasing demand from the consumer’s end. With the termination of Q3, the prices settled at USD 720115/MT CFR Hamburg with an average quarterly declination of 0.67%. 

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.